Severe toxicity and poor efficacy of reinduction chemotherapy are associated with overall poor outcomes in relapsed B-cell acute lymphoblastic leukemia: a report from the Children's Oncology Group AALL1331 trial. - Hogan LE; Bhatla T; Xu X; Gore L; Raetz EA; Bhojwani D; Teachey DT; Hunger SP; Loh ML; Brown PA; Ji L (Haematologica, 2025)